Harvest Health: Second Quarter Consensus Estimates

Harvest Health and Recreation (CSE: HARV) announced that they will be reporting their second quarter financials after the market closes on August 10.

Analysts have a consensus C$7 12-month price target on the company, via a total of 5 analysts, with one analyst having a strong buy rating, and the other 4 analysts having buy ratings. The street high comes from Alliance Global Partners with a C$9.50 price target, and the lowest target comes from Stifel-GMP with a C$5.50 price target.

Currently 4 analysts have revenue estimates for the second quarter. The mean between all 4 is $97.08 million; this number has been revised slightly higher from $87.08 million at the start of the year. The street high is $98.60 million while the lowest sits at $95.72 million.

Two analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 50.55%, with this number being revised slightly downwards from 51.70% at the start of the year. Street high goes to Stifel-GMP with a 53.50% estimate and the lowest sits at 47.60%.

Onto EBITDA estimates, there are currently 3 analysts who have second quarter EBITDA estimates. The mean is currently $26.82 million, with this number being higher than at the start of the year. Street high goes to Alliance Global with a $28.27 million EBITDA estimate and the lowest being a $26 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

Steadright Secures Two Additional Exploration Licenses For Flagship Project

First Majestic Posts Record Quarterly Silver Production In Q3

Related News

Tilray: Haywood Reiterates Hold Rating, $16.50 Price Target

With the Aphria, Tilray (NASDAQ: TLRY) merger finalized and Aphria shares consolidated earlier this month,...

Wednesday, May 19, 2021, 03:38:00 PM

BMO Reiterates $15 Price Target On Lundin Mining Following Investor Meeting

Last week, Lundin Mining Corporation (TSX: LUN) CEO Peter Rockandel sat down with BMO Capital...

Saturday, December 11, 2021, 12:49:00 PM

Starbucks: Analysts Expect Q1 Revenues Of $7.95 Billion

Starbucks (NASDAQ: SBUX) will be reporting its first quarter financial results on February 1st before...

Sunday, January 30, 2022, 05:29:00 PM

Cresco Labs: Canaccord Maintains Price Target Following FY2020 Results

Last week, Cresco Labs (CSE: CL) reported their fourth quarter and full-year 2020 financial results....

Monday, March 29, 2021, 11:44:00 AM

Organigram: Canaccord Lowers Price Target To $2.50

Yesterday, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) reported their fourth quarter financials. The company announced...

Tuesday, December 1, 2020, 11:17:00 AM